| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.8M | -15.8% | -9.5% |
| R&D Expense | $6.7M | -3.2% | -7.2% |
| SG&A Expense | $10.2M | -11.6% | -19.4% |
| Pre-tax Income | -$39.0M | -7.8% | +27.9% |
| Income Tax | $145K | +54.3% | +15.1% |
| Net Income | -$39.1M | -7.9% | +27.8% |
| EPS (Basic) | -$2.56 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $73.9M | -15.2% | -64.4% |
| Short-term Investments | $131.9M | -1.9% | +142.4% |
| Total Assets | $1.38B | +12.4% | +63.8% |
| Total Liabilities | $1.34B | +16.2% | +58.9% |
| Stockholders' Equity | $41.9M | -45.3% | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$109.3M | — | — |
| Capital Expenditures | $849K | — | — |
| Investing Cash Flow | -$589.5M | — | — |
| Financing Cash Flow | $555.4M | — | — |
| Free Cash Flow | -$110.2M | — | — |
| +28.5% |
| EPS (Diluted) | -$2.56 | -7.1% | +28.5% |